The article is 2012-2013 based and reader discretion is sought to ascertian the stage of approval Breast Cancer Drugs in Late-Stage Development/Recently Approved Afinitor® (everolimus) http://newdrugapprovals.wordpress.com/2013/04/27/drug-spotlight-afinitor-everolimus-novartis/ Sponsor: Novartis Method of Action: Mammalian target of rapamycin (mTOR) inhibitor Indications/Phase of Trial: Hepatocellular carcinoma; human epidermal growth factor receptor 2-positive (HER2+) breast cancer first-line and second-line; lymphoma; nonfunctional carcinoid… Continue reading Breast Cancer Drugs in Late-Stage Development/Recently Approved
Tag: Breast Cancer
From Cholesterol to Breast Cancer
The conversion of cholesterol into 27-hydroxycholesterol promotes the growth of hormone-dependent breast cancer Read more From Cholesterol to Breast Cancer